Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is O  [Clear All Filters]
Zou, R., Lan, Z., Wu, T., Jia, D., and Yang, Z. (2019). [Optimization of noni callus induction and establishment of callus suspension system].Sheng Wu Gong Cheng Xue Bao35, 298-306.
Sharma, A., Shah, S.Mohmad, Saini, N., Mehta, P., Kumar, B.S.Bharath, Dua, D., Singh, M.Kumar, Singla, S.Kumar, Palta, P., Manik, R.Sham, et al. (2019). Optimization of Serum-Free Culture Conditions for Propagation of Putative Buffalo (Bubalus bubalis) Spermatogonial Stem Cells.Cell Reprogram.
Xu, J., Cai, Y., Jiang, B., Li, X., Jin, H., Liu, W., Kong, Z., Hong, J., Sealy, J.E., Iqbal, M., et al. (2019). An optimized aptamer-binding viral tegument protein VP8 inhibits the production of Bovine Herpesvirus-1 through blocking nucleocytoplasmic shuttling.Int J Biol Macromol.
Batmunkh, M., Aksenova, S.V., Bayarchimeg, L., Bugay, A.N., and Lkhagva, O. (2019). Optimized neuron models for estimation of charged particle energy deposition in hippocampus.Phys Med57, 88-94.
Danoy, M., Bernier, M.Lereau, Kimura, K., Poulain, S., Kato, S., Mori, D., Kido, T., Plessy, C., Kusuhara, H., Miyajima, A., et al. (2019). Optimized protocol for the hepatic differentiation of iPSCs in a fluidic microenvironment.Biotechnol Bioeng.
Scruggs, B.A., Jiao, C., Cranston, C.M., Kaalberg, E., Wang, K., Russell, S.R., Wiley, L.A., Mullins, R.F., Stone, E.M., Tucker, B.A., et al. (2019). Optimizing Donor Cellular Dissociation and Subretinal Injection Parameters for Stem Cell-Based Treatments.Stem Cells Transl Med.
Borchman, D. (2019). The optimum temperature for the heat therapy for meibomian gland dysfunction.Ocul Surf.
Chen, T.-S., Liou, S.-Y., Lin, H.-H., Hung, M.-Y., Lin, C.-C., Lin, Y.-M., Lin, K.-H., V Padma, V., Yao, C.-H., Kuo, W.-W., et al. (2019). Oral administration of green tea Epigallocatechin-3-gallate reduces oxidative stress and enhances restoration of cardiac function in diabetic rats receiving autologous transplantation of adipose-derived stem cells.Arch Physiol Biochem1-8.
Kalff, A., Khong, T., Mithraprabhu, S., Bergin, K., Reynolds, J., Bowen, K.M., Thakurta, A., Guzman, R., Wang, M., Couto, S., et al. (2019). Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study).Leuk Lymphoma1-9.
Fall-Dickson, J.M., Pavletic, S.Z., Mays, J.W., and Schubert, M.M. (2019). Oral Complications of Chronic Graft-Versus-Host Disease.J Natl Cancer Inst Monogr2019.
Abdel-Kader, M.Ahmed, Abdelazeem, A.Farouk, Ahmed, N.El-Moataz, Khalil, Y.Mohamed, and Mostafa, M.Ibrahim (2019). Oral rehabilitation of a case with regional odontodysplasia using a regenerative approach-A case report and a review of literature.Spec Care Dentist.
Morrisette, T., Van Matre, A.G., Miller, M.A., Mueller, S.W., Bajrovic, V., Abidi, M.Z., Benamu, E., Kaiser, J.N., Barber, G.R., Chase, S., et al. (2019). Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplant and Hematologic Malignancy Population.Biol Blood Marrow Transplant.
Hanaford, A.R., Alt, J., Rais, R., Wang, S.Z., Kaur, H., Thorek, D.L.J., Eberhart, C.G., Slusher, B.S., Martin, A.M., and Raabe, E.H. (2019). Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma.Transl Oncol12, 1314-1322.
Ma, X., Qin, X., Shang, X., Liu, M., and Wang, X. (2019). Organic anion transport polypeptide 1b2 selectively affects the pharmacokinetic interaction between paclitaxel and sorafenib in rats.Biochem Pharmacol.
Tateno, H., Hiemori, K., Minoshima, F., Kiyoi, K., Matoba, K., Katayama, J., and Kumada, Y. (2019). Oriented immobilization of rBC2LCN lectin for highly sensitive detection of human pluripotent stem cells using cell culture supernatants.J Biosci Bioeng.
Wang, Y., Nicholes, K., and Shih, I.-M. (2019). The Origin and Pathogenesis of Endometriosis.Annu Rev Pharmacol Toxicol.
Pereira, A.R., Trivanovic, D., and Herrmann, M. (2019). Osteoarthritis as an organ disease: from the cradle to the graveApproaches to mimic the complexity of the skeletal mesenchymal stem/stromal cell niche in vitro.Eur Cell Mater37, 88-112.
Bourebaba, L., Röcken, M., and Marycz, K. (2019). Osteochondritis dissecans (OCD) in Horses - Molecular Background of its Pathogenesis and Perspectives for Progenitor Stem Cell Therapy.Stem Cell Rev.
Sari, D.Sandra, Maduratna, E., Latief, F.Dzar Eljab, Nugraha, A.Patera, Sudiana, K., and Rantam, F.Abdul (2019). Osteogenic Differentiation and Biocompatibility of Bovine Teeth Scaffold with Rat Adipose-derived Mesenchymal Stem Cells.Eur J Dent.
Rumiński, S., Kalaszczyńska, I., Długosz, A., and Lewandowska-Szumieł, M. (2019). Osteogenic differentiation of human adipose-derived stem cells in 3D conditions - comparison of spheroids and polystyrene scaffolds.Eur Cell Mater37, 382-401.
Westhauser, F., Karadjian, M., Essers, C., Senger, A.-S., Hagmann, S., Schmidmaier, G., and Moghaddam, A. (2019). Osteogenic differentiation of mesenchymal stem cells is enhanced in a 45S5-supplemented β-TCP composite scaffold: an in-vitro comparison of Vitoss and Vitoss BA.Plos One14, e0212799.
Srinaath, N., Balagangadharan, K., Pooja, V., Paarkavi, U., Trishla, A., and Selvamurugan, N. (2019). Osteogenic potential of zingerone, a phenolic compound in mouse mesenchymal stem cells.Biofactors.
Shanmugam, H., V Dharun, N., Biswal, B.Kumar, S Chandran, V., Vairamani, M., and Selvamurugan, N. (2019). Osteogenic stimulatory effect of heraclenin purified from bael in mouse mesenchymal stem cells in vitro.Chem Biol Interact108750.
Alam, M., Bertolini, M., Gherardini, J., Keren, A., Ponce, L., Chéret, J., Alenfall, J., Dunér, P., Nilsson, A.H., Gilhar, A., et al. (2019). An osteopontin-derived peptide inhibits human hair growth at least in part by decreasing FGF7 production in outer root sheath keratinocytes.Br J Dermatol.
Ringdén, O., Boumendil, A., Labopin, M., Canaani, J., Beelen, D., Ehninger, G., Niederwieser, D., Finke, J., Stelljes, M., Gerbitz, A., et al. (2019). OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OVER 69 YEARS OF AGE WITH ACUTE MYELOID LEUKEMIA: ON BEHALF OF THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT.Biol Blood Marrow Transplant.